Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trialShalini Makawita, Milind Javle, Ivan Borbath et al.|Future Oncology|2020Cited by 91
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Eric A. Collisson, Viswesh Krishna et al.|Cell Reports Medicine|2023Cited by 19